A Ferrant

937 citations
27 papers · 624 indexed · h-index 13

A Ferrant

27 papers receiving 597 citations

Peers

A Ferrant
Comparison fields: 5 of 52
  • Hematology 342
  • Genetics 189
  • Oncology 175
  • Emergency Medicine 56
  • Pathology and Forensic Medicine 102
Replace Eros Di Bona with:
Eros Di Bona Italy
G Broccia Italy
DP Deakin United Kingdom
H. Lumley United Kingdom
Abhishek Maiti United States
Estelle Verburgh South Africa
E. Odenwald Germany
Zafer Başlar Türkiye
G. Nedellec France
Tohru Sakura Japan
A Ferrant relative to Eros Di Bona Italy Eros Di Bona's profile →
Citations per field
00.5×2.5×
Eros Di Bona · 1×
Citations per year

Countries citing papers authored by A Ferrant

Since Specialization
Citations

This map shows the geographic impact of A Ferrant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Ferrant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Ferrant more than expected).

Fields of papers citing papers by A Ferrant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Ferrant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Ferrant. The network helps show where A Ferrant may publish in the future.

Co-authorship network

The 25 scholars most cited alongside A Ferrant, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A Ferrant Line = papers co-authored together A Ferrant links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 201135
2 201116
3 200959
4 20043
5 200121
6 200024
7 199722
8 19975
9 199520
10 19934
11 19922
12
The plicamycin and hydroxyurea combination chemotherapy for chronic granulocytic leukemia in myeloid transformation.
19911
13 199167
14
Megakaryoblastic leukemia with an N-ras mutation and late acquisition of a Philadelphia chromosome.
199110
15 199037
16 19892
17 19893
18 198740
19 198717
20 19871

About A Ferrant

A Ferrant is a scholar working on Hematology, Transplantation and Genetics, having authored 27 papers that have together received 624 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (11 papers), Chronic Lymphocytic Leukemia Research (6 papers), Acute Lymphoblastic Leukemia research (6 papers), Chronic Myeloid Leukemia Treatments (5 papers), Bone and Joint Diseases (4 papers), Hematological disorders and diagnostics (4 papers), Eosinophilic Disorders and Syndromes (3 papers) and Renal Transplantation Outcomes and Treatments (2 papers). The work is most often cited by research in Hematology (342 citations), Genetics (189 citations) and Oncology (175 citations). A Ferrant has collaborated with scholars based in Belgium, Italy and United Kingdom. Frequent co-authors include G. Sokal, Jl. Michaux, J Rodhain, A. Cordier, Herman Van den Berghe, J. Sonnet, Marc De Bruyère, M Moriau, Jean‐Louis Michaux and Philippe Martiat. Their work appears in journals such as Blood, British Journal of Haematology, Bone Marrow Transplantation, European Journal Of Haematology and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026